Gastric cancer (GC) is a common form of malignancy and one of the leading causes of cancer death worldwide. Although chemotherapy has been used to treat GC, immune checkpoint inhibitors, which have proven effective in treating other types of cancer, are now available for a substantial proportion of patients with advanced GC. This online activity describes available therapies for advanced GC, reviews data from clinical trials leading to the approval of immune checkpoint inhibitors for this indication, and discusses the recognition and management of immune-related adverse effects.
eNewsletter with interactive benchmarking
After completing this activity, participants should be better able to:
- Describe risk factors for and classification of GCs
- Select the treatment(s) most likely to benefit patients with advanced GC based on patient characteristics, previous treatment, and molecular biomarkers
- Address challenges to patient outcomes and quality of life by identifying and managing adverse effects of novel therapies
Oncology NPs, PAs, and nurses
Joint Accreditation Statement
In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
ANCC Credit Designation
CNE course advisor: Katie Zahasky, RN, MA, CNP, Winona State University, Winona, Minnesota
Nursing contact hours: 1.00, which includes 1.00 hour of pharmacology credit
AAPA Credit Designation
Practicing Clinicians Exchange has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. Approval is valid until August 14, 2021. PAs should only claim credit commensurate with the extent of their participation.
IPCE Credit Designation
This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.
This program was developed from a series of programs cosupported by educational grants from Astellas; Astellas and Pfizer; Celgene Corporation; Exelixis; GlaxoSmithKline; Karyopharm Therapeutics; Merck & Co., Inc.; Pharmacyclics LLC, an AbbVie Company; Sanofi Genzyme; Seattle Genetics; and Verastem Oncology.
This activity is supported by an educational grant from Merck & Co., Inc.
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.
All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange are required to disclose to the audience any relevant support or substantial relationships with providers of commercial products and/or devices discussed in this activity and/or with any commercial supporters of the activity. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and planning committee have been advised that this activity must be free from commercial bias, and based upon all the available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Dr Gibson has no relevant financial relationships to disclose.
Ms Zahasky has no relevant financial relationships to disclose.
None of the members of the PCE staff have any relevant relationships to disclose.
Participants wishing to earn CE/CME credit must:
- Read the content in its entirety
- Relate the content material to the learning objectives
- Complete the post-test and evaluation form
Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 70%. The estimated time to complete this activity is 1.00 hours.
Release date: August 15, 2020
Expiration date: August 14, 2021
© 2021 Practicing Clinicians Exchange. All Rights Reserved. 97520OPCE-7F